Abridge is an ambient AI documentation platform used in clinical visits: it listens to the conversation between a doctor and patient and generates a structured note in real time, so the clinician isn't typing or dictating during or after the appointment. It integrates directly with EHR systems, especially Epic, pulling the generated note into the patient chart and mapping relevant details to structured fields rather than leaving everything as free text. It also generates a patient-facing summary of the visit alongside the clinical note.
It's built for physicians and health systems trying to cut down on after-hours charting, sometimes called pajama time, that contributes heavily to clinician burnout. Deployment has scaled well beyond early adopters like UPMC, where founder and cardiologist Shiv Rao still practices, to systems including Mayo Clinic, Duke Health, Johns Hopkins, and Kaiser Permanente, spanning primary care, specialty, and emergency settings.
Abridge is one of the most heavily capitalized companies in ambient clinical documentation, having raised over $800 million including a $300 million Series E from Andreessen Horowitz and Khosla Ventures at a $5.3 billion valuation, with an additional extension round in 2026. It has been named Best in KLAS for Ambient AI in consecutive years and is co-developing a clinical foundation model with NVIDIA, with Eli Lilly also investing. That funding and scale distinguish it in a crowded field of AI scribes that includes Nuance DAX, Suki, and Nabla.
It's easier when you're signed in — Altern helps you get more out of AI.
By continuing you agree to our Terms and Privacy Policy.